cobalt has been researched along with afimoxifene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coradini, D; Daidone, MG; Pellizzaro, C; Speranza, A | 1 |
1 other study(ies) available for cobalt and afimoxifene
Article | Year |
---|---|
Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Hypoxia; Cobalt; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Receptors, Estrogen; Tamoxifen; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2004 |